参郁宁神片 | China Drugs ListShenyu Ningshen tablets | China Drugs List

本页为公开参考信息,不构成医疗建议、处方或药品供应要约。请向持证专业人士确认当前批准情况、可获得性及适用性。

企业
广东思济药业有限公司Guangdong Siji Pharmaceutical Co., Ltd.
药品类型
中成药Traditional Chinese medicine
治疗领域
精神健康与睡眠Mental health & sleep
公开来源记录的适应症
益气养阴、宁神解郁。用于轻、中度抑郁症中医辨证属气阴两虚证者,症见失眠多梦、多疑善惊、口咽干燥,舌淡红或红、苔薄白少津、脉细或沉细等In TCM, replenishes qi and nourishes yin, calms the mind and relieves constraint. For mild-to-moderate depression with deficiency of both qi and yin. Manifestations include insomnia and excessive dreaming, suspiciousness and being easily startled, dryness of the mouth and throat, a pale-red or red tongue with a thin white coating and scant fluid, and a fine or deep-fine pulse.
适应症来源与口径
来源日期: 2025, 2026. 适应症转录自国家医保局公开的企业申报资料;不代表已核实完整的现行说明书。Source date(s): 2025, 2026. Indications transcribed from the public NHSA manufacturer submission; this is not verification of the complete current label.
说明书信息局限
尚未取得可核实的完整药品说明书。现有批准记录或国家医保局申报资料支持所示适应症;最新完整范围尚待确认。A verifiable complete prescribing-information document has not yet been obtained. Available approval records or NHSA submissions support the indications shown; the latest full scope needs confirmation.
中国可获得性状态
已核实中国历史批准记录;尚未逐项核查每个产品目前是否持续上市销售。Historical Chinese approval verified; current continuous market availability has not been checked for every product.
海外状态
待逐一核查各市场。Market-by-market verification pending.
医保分类
已纳入国家医保(乙类)Included in national insurance (Category B)
医保版本
2025版;2026年1月1日起执行2025 edition; effective 1 January 2026
医保限制
益气养阴、宁神解郁。用于轻、中度抑郁症中医辨证属气阴两虚证者,症见失眠多梦、多疑善惊、口咽干燥,舌淡红或红、苔薄白少津、脉细或沉细等。Restricted to mild-to-moderate depression with the TCM pattern of qi and yin deficiency. TCM actions: replenishing qi and nourishing yin, calming the mind and relieving constraint. Manifestations include insomnia and excessive dreaming, suspiciousness and being easily startled, dry mouth and throat, a pale-red or red tongue with a thin white coating and scant fluid, and a fine or deep-fine pulse.
医保期限
2026-01-01 至 2027-12-312026-01-01 to 2027-12-31
医保核查说明
按成分/剂型名称精确或标准化匹配。报销仍取决于剂型及目录所列支付限制。Matched by exact or normalized ingredient/formulation name. Reimbursement still depends on the dosage form and listed payment restrictions.

来源

打开交互详情、公开价格与讨论